UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer

Journal of Surgical Oncology

Volumn 115, Issue 8, 2017, Pages 932-940

  Ning, Kuan ^a,b   Wang, Teng ^a   Sun, Xu ^a   Zhang, Pengfei ^b   Chen, Yun ^b   Jin, Jian ^b   Hua, Dong ^a  

^a Soochow University   (China)

^b JIANGNAN UNIVERSITY   (China)

Author keywords

breast cancer; chemotherapeutic resistance transfer; exosomes; UCH L1

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MULTIDRUG RESISTANCE PROTEIN; TAXANE DERIVATIVE; UBIQUITIN CARBOXYL TERMINAL HYDROLASEL1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; BREAST CANCER CELL LINE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RESISTANCE; CELL TRANSFER; CONTROLLED STUDY; EXOSOME; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MCF-7 CELL LINE; MICROENVIRONMENT; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; AGED; BREAST TUMOR; CELL CULTURE TECHNIQUE; DRUG RESISTANCE; METABOLISM; PATHOLOGY; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE, SUB-FAMILY B, MEMBER 1; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; EXOSOMES; FEMALE; HUMANS; MIDDLE AGED; UBIQUITIN THIOLESTERASE;

EID: 85016421621     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.24614     Document Type: Article

References (31)

1. Parrella P. Epigenetic signatures in beast cancer: clinical perspective. Breast Care. 2010; 5:66–73.
2. Li QQ, Wang WJ, Xu JD, et al. Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. Cancer Sci. 2007; 98:1064–1069.
3. Zhang P, He D, Chen Z, et al. Chemotherapy enhances tumor vascularization via Notch signaling-mediated formation of tumor-derived endothelium in breast cancer. Biochem Pharmacol. 2016; 118:18–30.
4. Chen Z, Tang C, Zhu Y, et al. TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer. Clin Sci. 2017; 131:227–237.
5. Foo J, Michor F. Evolution of acquired resistance to anti-cancer therapy. J Theor Biol. 2014; 355:10–20.
6. Gottesman MM. Mechanisms of cancer drug resistance. Ann Rev Med. 2002; 53:615–627.
7. Wang T, Chen Z, Zhu Y, et al. Inhibition of transient receptor potential channel 5 reverses 5-fluorouracil resistance in human colorectal cancer cells. J Biol Chem. 2015; 290:448–456.
8. Levchenko A, Mehta BM, Niu X, et al. Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc Natl Acad Sci USA. 2005; 102:1933–1938.
9. Ma X, Chen Z, Hua D, et al. Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance. Proc Natl Acad Sci USA. 2014; 111:6389–6394.
10. Torrano V, Royo F, Peinado H, et al. Vesicle-MaNiA: extracellular vesicles in liquid biopsy and cancer. Curr Opin Pharmacol. 2016; 29:47–53.
11. Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015; 523:177–182.
12. Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008; 319:1244–1247.
13. Al-Nedawi K, Meehan B, Micallef J, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008; 10:619–624.
14. Demory Beckler M, Higginbotham JN, Franklin JL, et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics. 2013; 12:343–355.
15. Kahlert C, Melo SA, Protopopov A, et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem. 2014; 289:3869–3875.
16. Anastasiadou E, Slack FJ. Cancer. Malicious exosomes. Science. 2014; 346:1459–1460.
17. Wilkinson KD, Lee KM, Deshpande S, et al. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science. 1989; 246:670–673.
18. Miyoshi Y, Nakayama S, Torikoshi Y, et al. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci. 2006; 97:523–529.
19. Tezel E, Hibi K, Nagasaka T, Nakao A. PGP9.5 as a prognostic factor in pancreatic cancer. Clin Cancer Res. 2000; 6:4764–4767.
20. Wang W, Zou L, Zhou D, et al. Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway. Mol Carcinog. 2016; 55:1329–1342.
21. Tanabe M, Ieiri I, Nagata N, et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther. 2001; 297:1137–1143.
22. Altan N, Chen Y, Schindler M, Simon SM. Tamoxifen inhibits acidification in cells independent of the estrogen receptor. Proc Natl Acad Sci USA. 1999; 96:4432–4437.
23. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;Chapter 3:Unit 3.22.1–3.22.29.
24. Bang C, Batkai S, Dangwal S, et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest. 2014; 124:2136–2146.
25. Gong B, Cao Z, Zheng P, et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell. 2006; 126:775–788.
26. Ambudkar SV, Sauna ZE, Gottesman MM, Szakacs G. A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1). Trends Pharmacol Sci. 2005; 26:385–387.
27. Lv MM, Zhu XY, Chen WX, et al. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumour Biol. 2014; 35:10773–10779.
28. Kharaziha P, Ceder S, Li Q, Panaretakis T. Tumor cell-derived exosomes: a message in a bottle. Biochim Biophys Acta. 2012; 1826:103–111.
29. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9:654–659.
30. Simons M, Raposo G. Exosomes–vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009; 21:575–581.
31. De Toro J, Herschlik L, Waldner C, Mongini C. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol. 2015; 6:203.